With an EV of just circa $26m You almost couldn't even run OA from start to full clinical result readout for that.
so the market is applying no valuation on any other current or possible indication on Cymerus pipeline...or the underlying tech/patents themselves
R/R at 30c/ this valuation is multibags. FIL have paid up to $1.53 Sumitomo $2.02 eq offer at time. If you don't have the patience, I'd say stick more in super.
Volumes last 6 months have been smallest in the last 9 years...signalling a bottom is in. maybe a triple bottom. (cue the nutbag cult)
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
)
(20min delay)